
Date:
March 2026
Issue:
313
File Type:
PDF
Includes: New characteristics of aggressive prostate cancer identified, PSMA PET/CT–Guided Radiation Exhibits Favorable Prostate Cancer Outcomes, Study shows strong evidence for effectiveness of metastasis-directed radiation therapy in prostate cancer, Vanquish Water Vapor System used in first commercial prostate ablation, New study unlocks important information about how to treat recurring prostate cancer, Head-to-head analysis shows OS benefit with apalutamide vs darolutamide in mCSPC, and more.
